Sun Pharma's arm Taro resolves all cases with United States Department of Justice

Under a deferred prosecution agreement reached with the DOJ, it said, adding that the dept will file an information for conduct that took place between 2013 and 2015. Taro Pharmaceutical said, if the company adheres to the terms of the agreement, including the payment of USD 205.7 million, the DOJ will dismiss the information at the end of a 3-year period.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3jy20NX
via IFTTT